MiRNA-375 regulates the cell survival and apoptosis of human non-small cell carcinoma by targeting HER2

Molecular Medicine Reports

Volumn 15, Issue 3, 2017, Pages 1387-1392

  Cheng, Longqiang ^a   Zhan, Bingxiang ^a   Luo, Peng ^a   Wang, Baolong ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; HER2; MiR 375; Non small cell lung cancer cell; Proliferation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MICRORNA 375; 3' UNTRANSLATED REGION; MICRORNA; MIRN375 MICRORNA, HUMAN;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; 3' UNTRANSLATED REGION; ANIMAL; CELL MOTION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; RNA INTERFERENCE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICRORNAS; RECEPTOR, ERBB-2; RNA INTERFERENCE;

EID: 85013842909     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2017.6112     Document Type: Article

References (27)

1. Hoffman PC, Mauer AM and Vokes EE: Lung cancer. Lancet 355: 479-485, 2000.
2. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L and Kunkler I; EUROCARE-4 Working Group: Recent cancer survival in Europe: A 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8: 784-796, 2007.
3. Liu XH, Lu KH, Wang KM, Sun M, Zhang EB, Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, et al: MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. BMC Cancer 12: 348, 2012.
4. Ma Q, Jiang Q, Pu Q, Zhang X, Yang W, Wang Y, Ye S, Wu S, Zhong G, Ren J, et al: MicroRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism. Int J Biol Sci 9: 680-692, 2013.
5. Liu Y, Li M, Zhang G and Pang Z: MicroRNA-10b overexpression promotes non-small cell lung cancer cell proliferation and invasion. Eur J Med Res 18: 41, 2013.
6. Chi SW, Zang JB, Mele A and Darnell RB: Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460: 479-486, 2009.
7. Hale BJ, Yang CX and Ross JW: Small RNA regulation of reproductive function. Mol Reprod Dev 81: 148-159, 2014.
8. Farazi TA, Spitzer JI, Morozov P and Tuschl T: miRNAs in human cancer. J Pathol 223: 102-115, 2011.
9. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
10. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
11. Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, Ge C, Yao J, Chen T, Wan D, et al: Gain of MIR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDiA. Nat Cell Biol 12: 390-399, 2010.
12. Ma L, Teruya-Feldstein J and Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688, 2007.
13. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW and Weinberg RA: Therapeutic silencing of mir-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 28: 341-347, 2010.
14. Cho WC: MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 42: 1273-1281, 2010.
15. Cho WC: MicroRNAs in cancer-from research to therapy. Biochim Biophys Acta 1805: 209-217, 2010.
16. Gabriely G, Teplyuk NM and Krichevsky AM: Context effect: microRNA-10b in cancer cell proliferation, spread and death. Autophagy 7: 1384-1386, 2011.
17. Li Y, Jiang Q, Xia N, Yang H and Hu C: Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance. J Int Med Res 40: 1662-1669, 2012.
18. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
19. Wang Y and Lee CG: MicroRNA and cancer-focus on apoptosis. J Cell Mol Med 13: 12-23, 2009.
20. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P and Stoffel M: A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230, 2004.
21. Avnit-Sagi T, Kantorovich L, Kredo-Russo S, Hornstein E and Walker MD: The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas. PLoS One 4: e5033, 2009.
22. Liu AM, Poon RT and Luk JM: MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun 394: 623-627, 2010.
23. Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P, Zavolan M and Stoffel M: MIR-375 maintains normal pancreatic alpha-and beta-cell mass. Proc Natl Acad Sci USA 106: 5813-5818, 2009.
24. Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD and Plasterk RH: Targeted inhibition of miRNA maturation with morpholinos reveals a role for MIR-375 in pancreatic islet development. PLoS Biol 5: e203, 2007.
25. Shen ZY, Zhang ZZ, Liu H, Zhao EH and Cao H: MIR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression. Exp Ther Med 7: 1757-1761, 2014.
26. Zhang ZW, Men T, Feng RC, Li YC, Zhou D and Teng CB: MIR-375 inhibits proliferation of mouse pancreatic progenitor cells by targeting YAP1. Cell Physiol Biochem 32: 1808-1817, 2013.
27. Mitri Z, Constantine T and O'Regan R: The HER2 receptor in breast cancer: Pathophysiology, clinical use and new advances in therapy. Chemother Res Pract 2012: 743193, 2012.